CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming investor conferences. Details regarding Lifecore’s participation are as follows:

• Morgan Stanley 23^rd Annual Global Healthcare Conference
  Details: Lifecore management will participate in a fireside chat and in investor meetings
  Conference Dates: September 8-10, 2025
  Fireside Chat Time: 4:50 – 5:25 p.m. Eastern on Tuesday, September 9, 2025, webcast available
  Location: New York, NY

• Barrington Research Virtual Fall Investment Conference
  Details: Lifecore management will participate in investor meetings
  Conference Date: September 16, 2025
  Location: Virtual

• Jefferies CDMO Summit 2025
  Details: Lifecore management will participate in investor meetings
  Conference Date: September 17, 2025
  Location: London, UK

A live webcast of the Morgan Stanley fireside chat may be accessed via a link on Lifecore’s investor website on the Investor Events & Presentations page at: https://ir.lifecore.com/events-presentations. Additionally, a replay of the webcast will be available on the Lifecore website following the conference.

About Lifecore Biomedical

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.